Conquer Challenges, Deliver Hope
As science forges ahead into new discoveries, there are more clinical trials than ever before. Yet today’s focus on precision medicine and increasingly sophisticated protocol designs have resulted in clinical trials that are more complex, challenging to execute and costly, as well more burdensome to sites and patients.
The COVID-19 pandemic added new obstacles and complexity on top of the already difficult environment, creating enormous adaptive pressure on the entire clinical trial ecosystem, hastening adoption of new clinical research paradigms, and accelerating emerging trends. But will they sustain? In this paper, we will delve into hot topics impacting research today.